Omeros OMER
NASDAQ OMER
$19.04 -0.07 (-0.37%)
As of: Sep 4, 2026 · 2:37 PM EDT

Omeros (OMER) Consolidated Net Income (2010 - 2026)

Omeros (OMER) posted Consolidated Net Income of $4.8 million for Q1 2026, down 26.67% sequentially from $6.6 million in Q4 2025, and up 17.2% YoY from $4.1 million in Q1 2025.

Analysis

Omeros (OMER) Consolidated Net Income (2010 - 2026) Analysis & Trends

Omeros has reported Consolidated Net Income for 17 years, with the latest figure at $4.8 million in Q1 2026.

  • Quarterly Consolidated Net Income rose 17.2% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 90.69% YoY) and the FY2025 annual result came in at $1.5 million, down 94.35% from the prior year.
  • Consolidated Net Income declined to $4.8 million in Q1 2026 per OMER's latest filing, from $6.6 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $174.8 million in Q4 2022 and troughed at -$9.7 million in Q3 2025.
  • A 5-year average of $18.7 million and a median of $6.6 million in 2025 frame the typical range for Consolidated Net Income.
  • The sharpest annual moves came in 2022 and 2025: Consolidated Net Income surged 73.05% in 2022, then tumbled 298.2% in 2025.
  • Over 5 years, Consolidated Net Income stood at $174.8 million in 2022, then sank by 82.71% to $30.2 million in 2023, then plunged by 82.85% to $5.2 million in 2024, then gained by 26.59% to $6.6 million in 2025, then retreated by 26.67% to $4.8 million in 2026.
  • According to Business Quant data, Consolidated Net Income over the past three periods registered $4.8 million, $6.6 million, and -$9.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 601.00 Mn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -644.37 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - 81.49 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -13.27 Mn
10 Omeros 1.37 Bn 1.37 Bn 27.73 Mn 13.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.23 Mn
Mar 31, 2026 56.06 Mn
Dec 31, 2025 -30.13 Mn
Sep 30, 2025 -22.10 Mn
Jun 30, 2025 -25.42 Mn
Mar 31, 2025 -33.46 Mn
Dec 31, 2024 -29.07 Mn
Sep 30, 2024 -32.23 Mn
Jun 30, 2024 -56.04 Mn
Mar 31, 2024 -37.18 Mn
Dec 31, 2023 -13.18 Mn
Sep 30, 2023 -37.75 Mn
Jun 30, 2023 -37.29 Mn
Mar 31, 2023 -33.70 Mn
Dec 31, 2022 -96.76 Mn
Sep 30, 2022 -17.46 Mn
Jun 30, 2022 -30.85 Mn
Mar 31, 2022 -33.01 Mn
Dec 31, 2021 -162.00 Mn
Sep 30, 2021 -1.13 Mn